| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |